New Research: Key Drivers of Growth for Masco, Dextera Surgical, PTC Therapeutics, American International Group, Wyndham Worldwide, and Hecla Mining - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained - American Intl Gr (NYSE:AIG)

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Masco Corporation MAS, Dextera Surgical Inc. DXTR, PTC Therapeutics, Inc. PTCT, American International Group, Inc. AIG, Wyndham Worldwide Corporation WYN, and Hecla Mining Company HL including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MAS DOWNLOAD: http://Fundamental-Markets.com/register/?so=MAS

DXTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=DXTR

PTCT DOWNLOAD: http://Fundamental-Markets.com/register/?so=PTCT

AIG DOWNLOAD: http://Fundamental-Markets.com/register/?so=AIG

WYN DOWNLOAD: http://Fundamental-Markets.com/register/?so=WYN

HL DOWNLOAD: http://Fundamental-Markets.com/register/?so=HL

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Masco Corporation MAS, Dextera Surgical Inc. DXTR, PTC Therapeutics, Inc. PTCT, American International Group, Inc. AIG, Wyndham Worldwide Corporation WYN, and Hecla Mining Company HL on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 8, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

MASCO CORPORATION (MAS) REPORT OVERVIEW

Masco's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Masco reported revenue of $1,936 vs $1,877 (up 3.1%), diluted earnings per share $0.46 vs $0.40 (up 15.0%) and dividends per share $0.100 vs $0.095 (up 5.3%). For the twelve months ended December 31, 2016 vs December 31, 2015, Masco reported revenue of $7,357 vs $7,142 (up 3.0%), diluted earnings per share $1.47 vs $1.03 (up 42.7%), and dividends per share $0.39 vs $0.37 (up 5.4%).

To read the full Masco Corporation (MAS) report, download it here: http://Fundamental-Markets.com/register/?so=MAS

-----------------------------------------

DEXTERA SURGICAL INC. (DXTR) REPORT OVERVIEW

Dextera Surgical's Recent Financial Performance

For the three months ended March 31, 2017 vs March 31, 2016, Dextera Surgical reported revenue of $1.1 vs $1.9 (down 42.1) and diluted earnings per share -$0.50 vs -$0.34. For the twelve months ended June 30, 2017 vs June 30, 2016, Dextera Surgical reported revenue of $3.40 vs $4.10 (down 17.1%) and diluted earnings per share -$2.33 vs -$1.79. Dextera Surgical is expected to report earnings on 11/09/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.06. The reported EPS for the same quarter last year was -$0.44.

To read the full Dextera Surgical Inc. (DXTR) report, download it here: http://Fundamental-Markets.com/register/?so=DXTR

-----------------------------------------

PTC THERAPEUTICS (PTCT) REPORT OVERVIEW

PTC Therapeutics's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, PTC Therapeutics reported revenue of $41.9 vs $23.0 (up 82.2%) and diluted earnings per share -$0.82 vs -$1.03. For the twelve months ended December 31, 2016 vs December 31, 2015, PTC Therapeutics reported revenue of $82.7 vs $36.8 (up 124.7%) and diluted earnings per share -$4.17 vs -$5.07.

To read the full PTC Therapeutics, Inc. (PTCT) report, download it here: http://Fundamental-Markets.com/register/?so=PTCT

-----------------------------------------

AMERICAN INTERNATIONAL GROUP (AIG) REPORT OVERVIEW

American International Group's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, American International Group reported revenue of $11,751 vs $12,854 (down 8.6%), diluted earnings per share -$1.91 vs $0.42, and dividends per share $0.32 vs $0.32 (unchanged). For the twelve months ended December 31, 2016 vs December 31, 2015, American International Group reported revenue of $52,367 vs $58,327 (down 10.2%), diluted earnings per share -$0.78 vs $1.65, and dividends per share $1.28 vs $0.81 (up 58.0%).

To read the full American International Group, Inc. (AIG) report, download it here: http://Fundamental-Markets.com/register/?so=AIG

-----------------------------------------

WYNDHAM WORLDWIDE (WYN) REPORT OVERVIEW

Wyndham Worldwide's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Wyndham Worldwide reported revenue of $1,629 vs $1,573 (up 3.6%), diluted earnings per share $1.97 vs $1.78 (up 10.7%), and dividends per share $0.58 vs $0.50 (up 16.0%). For the twelve months ended December 31, 2016 vs December 31, 2015, Wyndham Worldwide reported revenue of $5,599 vs $5,536 (up 1.1%), diluted earnings per share $5.53 vs $5.14 (up 7.6%), and dividends per share $2.00 vs $1.68 (up 19.1%).

To read the full Wyndham Worldwide Corporation (WYN) report, download it here: http://Fundamental-Markets.com/register/?so=WYN

-----------------------------------------

HECLA MINING COMPANY (HL) REPORT OVERVIEW

Hecla Mining's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Hecla Mining reported revenue of $134.3 vs $171.3 (down 21.6%), diluted earnings per share -$0.06 vs $0.06, and dividends per share $0.0025 vs $0.0025 (unchanged). For the twelve months ended December 31, 2016 vs December 31, 2015, Hecla Mining reported revenue of $646.0 vs $443.6 (up 45.6%), diluted earnings per share $0.18 vs -$0.23, and dividends per share $0.01 vs $0.01 (unchanged).

To read the full Hecla Mining Company (HL) report, download it here: http://Fundamental-Markets.com/register/?so=HL

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Market News and Data brought to you by Benzinga APIs